trial · primary record
MPH966
Chronic Graft vs Host Disease
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 16 |
| Primary completion | 2027-12-01 |
| Primary endpoint | Optimal biologic dose (OBD) based on maximal NE inhibition measured in sputum |
| Registry ID | NCT02669251 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:51.700Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT02669251
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.